Aggrenox indications

Jump to: navigation, search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Aggrenox® (aspirin/extended-release dipyridamole) capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.


Adapted from the FDA Package Insert.


Linked-in.jpg